Montelukast is used to control
and prevent symptoms caused by asthma (such as wheezing and shortness of
breath). It is also used before exercise to prevent breathing problems during
exercise (bronchospasm).
Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose).
Common Asthma Symptoms
·
Patient need to take this medication at the same
time of each day. If they are taking this medication for asthma or for both
asthma and allergies, should take their dose in the evening.
·
If they are taking montelukast to prevent only
allergies, should take their dose either in the morning or the evening.
· If patient are taking this medication to prevent breathing problems during exercise, should take the dose at least 2 hours before exercise.
NOTE:
There have been no clinical trials evaluating the relative efficacy of morning versus evening dosing. Also, no difference in pharmacokinetics was noted between morning and evening dosing.
Shouldn’t take more than one dose in 24 hours. Should not take a dose
before exercise if they are already taking this medication daily for asthma or
allergies.
Patient usually prescribed to
take montelukast once a day.
For the treatment of Asthma, it's
taken at night because asthma symptoms tend to be worse at
night. Administration of montelukast at evening ensures that maximal
plasma concentrations of the drug coincide with the early morning maximal
airway narrowing.
Montelukast typically starts to
work after the first dose, but it can take up to a week for some people to
notice a change in their symptoms.
Unlike antihistamines, montelukast can't be taken as needed. It
typically needs about 3 to 7 days.
This medication must be used regularly to be effective. It does
not work right away and should not be used to relieve sudden asthma attacks or
breathing problems.
There is strong evidence to
suggest that leukotrienes are also involved in decreasing persistent cough
following viral or whooping cough infection. Montelukast may therefore also
help settle persistent coughs in these settings.
Collectively, these data suggest
that long-term treatment with montelukast is safe and improves COPD control in
elderly patients with moderate to severe COPD.
Neuropsychiatric disorders as
side effects of montelukast were more frequently reported for children than for
adults. Infants and children seem to be more prone to sleep disturbances,
whereas adolescents present symptoms of depression/anxiety and psychotic
reactions more often.
https://www.webmd.com/drugs/2/drug-6478-8277/montelukast-oral/montelukast-oral/details
https://www.drugs.com/mtm/montelukast.html
https://www.nhs.uk/medicines/montelukast/
https://pubmed.ncbi.nlm.nih.gov/16429427/
https://clinicaltrials.gov/ct2/show/NCT01279668
https://pubmed.ncbi.nlm.nih.gov/14971876/
https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-boxed-warning-about-serious-mental-health-side-effects-asthma-and-allergy-drug
Note: For
informational purposes only. Consult your textbook for advising your patients.
Comments
You must login to write comment